Sergio Escobedo

689 total citations
12 papers, 529 citations indexed

About

Sergio Escobedo is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sergio Escobedo has authored 12 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Gastroenterology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Sergio Escobedo's work include Gastroesophageal reflux and treatments (9 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Gastrointestinal motility and disorders (4 papers). Sergio Escobedo is often cited by papers focused on Gastroesophageal reflux and treatments (9 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Gastrointestinal motility and disorders (4 papers). Sergio Escobedo collaborates with scholars based in Canada, Mexico and United Kingdom. Sergio Escobedo's co-authors include David Armstrong, Alan Barkun, Naoki Chiba, S. J. O. Veldhuyzen van Zanten, A. B. R. Thomson, Bijan Chakraborty, Paul Sinclair, Robert J. White, Sandra Daniels and Krista Nevin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Sergio Escobedo

12 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio Escobedo Canada 9 459 403 75 19 15 12 529
Bjørn Bernersen Norway 8 505 1.1× 421 1.0× 69 0.9× 15 0.8× 33 2.2× 10 567
Ein Soon Shin South Korea 6 273 0.6× 182 0.5× 113 1.5× 18 0.9× 15 1.0× 8 369
Villy Meineche-Schmidt Denmark 12 351 0.8× 346 0.9× 37 0.5× 22 1.2× 22 1.5× 25 440
A. Dalväg Switzerland 5 610 1.3× 612 1.5× 68 0.9× 8 0.4× 23 1.5× 5 679
Börje Wernersson Sweden 15 752 1.6× 735 1.8× 109 1.5× 36 1.9× 15 1.0× 30 892
H O’Flanagan United Kingdom 6 281 0.6× 342 0.8× 71 0.9× 59 3.1× 15 1.0× 7 395
Monica Nandwani United States 11 274 0.6× 274 0.7× 33 0.4× 43 2.3× 21 1.4× 25 379
Jens Hansen Denmark 9 395 0.9× 324 0.8× 73 1.0× 23 1.2× 37 2.5× 13 518
Frederick W. Woodley United States 13 303 0.7× 346 0.9× 176 2.3× 22 1.2× 33 2.2× 30 507
Nathaniel S. Winstead United States 7 152 0.3× 147 0.4× 30 0.4× 23 1.2× 8 0.5× 10 267

Countries citing papers authored by Sergio Escobedo

Since Specialization
Citations

This map shows the geographic impact of Sergio Escobedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Escobedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Escobedo more than expected).

Fields of papers citing papers by Sergio Escobedo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Escobedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Escobedo. The network helps show where Sergio Escobedo may publish in the future.

Co-authorship network of co-authors of Sergio Escobedo

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Escobedo. A scholar is included among the top collaborators of Sergio Escobedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Escobedo. Sergio Escobedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Escobedo, Sergio, et al.. (2013). Factores de riesgo asociados al desarrollo de fístula anal. 35(1). 25–31. 1 indexed citations
2.
Barkun, Alan, Ralph Crott, Carlo A Fallone, et al.. (2010). A One-Year Economic Evaluation of Six Alternative Strategies for the Management of Uninvestigated Upper Gastrointestinal Symptoms in Canadian Primary Care. SHILAP Revista de lepidopterología. 24(8). 489–498. 9 indexed citations
3.
Zanten, S. J. O. Veldhuyzen van, Naoki Chiba, David Armstrong, et al.. (2006). Validation of a 7‐point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Alimentary Pharmacology & Therapeutics. 23(4). 521–529. 78 indexed citations
4.
Zanten, S. J. O. Veldhuyzen van, A. B. R. Thomson, Alan Barkun, et al.. (2006). The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Alimentary Pharmacology & Therapeutics. 23(5). 595–599. 38 indexed citations
5.
Zanten, S. J. O. Veldhuyzen van, Naoki Chiba, David Armstrong, et al.. (2005). A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study. The American Journal of Gastroenterology. 100(7). 1477–1488. 88 indexed citations
7.
Chiba, Naoki, S. J. O. Veldhuyzen van Zanten, Sergio Escobedo, et al.. (2004). Economic evaluation of Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial of H. pylori‐positive primary care patients with uninvestigated dyspepsia. Alimentary Pharmacology & Therapeutics. 19(3). 349–358. 29 indexed citations
8.
Thomson, A. B. R., Alan Barkun, David Armstrong, et al.. (2003). The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study. Alimentary Pharmacology & Therapeutics. 17(12). 1481–1491. 210 indexed citations
9.
Armstrong, David, et al.. (2003). Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Alimentary Pharmacology & Therapeutics. 18(7). 705–711. 27 indexed citations
10.
Chiba, Naoki, Alan Thomson, Alan Barkun, et al.. (2003). The ROME II definition of dyspepsia does not exclude patients with gastroesophageal reflux disease (GERD) in primary care. Gastroenterology. 124(4). A223–A224. 3 indexed citations
11.
Barquera, Sı́món, et al.. (2001). Bronchial asthma healthcare costs in Mexico: analysis of trends from 1991-1996 with information from the Mexican Institute of Social Security.. PubMed. 10(6). 334–41. 7 indexed citations
12.
Schwarz, Stephan, Luigi G. Franciosi, Craig R. Ries, et al.. (1999). Addition of femoral 3-in-1 blockade to intra-articular ropivacaine 0.2% does not reduce analgesic requirements following arthroscopic knee surgery. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 46(8). 741–747. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026